Table 3.
Comparison between patients who died and survived
| Parameter | Patients who died (n = 6) | Survivors (n = 9) | P-value |
|---|---|---|---|
| Age (years), mean (SD) | 75.46 (10.04) | 76.3 (12.32) | 0.89 |
| Dialysis vintage (years) | 2.89 (0.14–5.06) | 5.71 (1.36–9) | 0.22 |
| Sex (% of males) | 83.33 | 88.89 | 1 |
| Body mass index, mean (SD) | 25.55 (4.41) | 24.98 (4.08) | 0.81 |
| Diabetes (%) | 83.33 | 33.33 | 0.12 |
| Obesity (%) | 33.33 | 22.22 | 1 |
| Lowest pO2 (mmHg) | 53 (47.95–104) | 60 (54.9–72) | 1 |
| Lowest pO2:FIO2 | 100 (50–377.5) | 274 (146–300) | 0.5 |
| White blood cell count nadir (n/uL) | 5655 (5153–8497) | 4800 (4375–6305) | 0.18 |
| Lymphocyte count nadir (n/uL) | 540 (465–2135) | 705 (545–995) | 0.75 |
| Lactate dehydrogenase zenith (U/L) | 548 (444–1383) | 532 (421–870) | 0.63 |
| D-dimer zenith (ng/L) | 1510 (1330–1860) | 2445 (892–3965) | 1 |
| Platelets nadir (n/uL) | 141 (105–247) | 166 (107–220) | 0.9 |
| C-reactive protein zenith (mg/dL) | 26.15 (16.93–34.38) | 7.5 (4.35–13.15) | 0.02 |
| IL-6 zenith (pg/mL) | 470 (355.8–2405) | 152.8 (107.9–1241) | 0.14 |
| Specific treatments (%) | |||
| Hydroxychloroquine | 66.66 | 88.88 | 0.52 |
| Azithromycin | 33.33 | 44.44 | 1 |
| Darunavir/cobicistat | 16.66 | 11.11 | 1 |
| Heparin | 44.44 | 33.33 | 1 |
| Tocilizumab | 0 | 11.11 | 1 |
Values are expressed as median (IQR) unless stated otherwise.